Cargando…
Recent Advances in Next Generation Snakebite Antivenoms
With the inclusion of snakebite envenoming on the World Health Organization’s list of Neglected Tropical Diseases, an incentive has been established to promote research and development effort in novel snakebite antivenom therapies. Various technological approaches are being pursued by different rese...
Autores principales: | Knudsen, Cecilie, Laustsen, Andreas H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073149/ https://www.ncbi.nlm.nih.gov/pubmed/30274438 http://dx.doi.org/10.3390/tropicalmed3020042 |
Ejemplares similares
-
Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims †
por: Kini, R. Manjunatha, et al.
Publicado: (2018) -
The Need for Next-Generation Antivenom for Snakebite Envenomation in India
por: Vanuopadath, Muralidharan, et al.
Publicado: (2023) -
Cost of Manufacturing for Recombinant Snakebite Antivenoms
por: Jenkins, Timothy Patrick, et al.
Publicado: (2020) -
Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
por: Laustsen, Andreas H., et al.
Publicado: (2017) -
Antibodies as Snakebite Antivenoms: Past and Future
por: Dias da Silva, Wilmar, et al.
Publicado: (2022)